cephalosporin c has been researched along with omeprazole in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Ikeda, F; Mine, Y; Yokoya, Y | 1 |
Alarcón, T; Díaz de Rojas, F; Domingo, D; López-Brea, M; Sánchez, I | 1 |
Smith, BB | 1 |
Barbaud, A | 1 |
Alhaja, M; Dorrestein, PC; Jarmusch, AK; Knight, R; Liyanage, M; Ma, JD; Momper, JD; Tsunoda, SM; Vrbanac, A | 1 |
5 other study(ies) available for cephalosporin c and omeprazole
Article | Year |
---|---|
[Antibacterial activity of cefdinir and omeprazole against Helicobacter pylori and their inhibition on H. pylori-producing urease].
Topics: Cefdinir; Cephalosporins; Drug Synergism; Helicobacter pylori; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Omeprazole; Urease | 1993 |
In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Ceftibuten; Cephalosporins; Clarithromycin; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Endoscopy; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Omeprazole; Penicillins; Stomach | 1996 |
An overview of selected diseases and drug needs in the llama and alpaca industries.
Topics: Animal Husbandry; Animals; Anthelmintics; Anti-Ulcer Agents; Antinematodal Agents; Bacterial Infections; Camelids, New World; Cephalosporins; Drug Approval; Ivermectin; North America; Omeprazole; Parasitic Diseases, Animal; Stomach Ulcer; Sulfanilamides; Veterinary Drugs | 1998 |
[Current findings on drug-induced skin reactions].
Topics: Cephalosporins; Drug Eruptions; France; Glucocorticoids; Humans; Hypersensitivity, Delayed; Lansoprazole; Omeprazole; Penicillins; Taxoids; Xenobiotics | 2017 |
Enhanced Characterization of Drug Metabolism and the Influence of the Intestinal Microbiome: A Pharmacokinetic, Microbiome, and Untargeted Metabolomics Study.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefprozil; Cephalosporins; Cross-Over Studies; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Interactions; Feces; Female; Gastrointestinal Microbiome; Healthy Volunteers; Humans; Male; Metabolomics; Middle Aged; Omeprazole; Pharmacogenomic Testing; Pharmacogenomic Variants; Prospective Studies; Young Adult | 2020 |